Novo Nordisk makes AWS its primary AI partner

Novo Nordisk named AWS its primary cloud and strategic AI partner and will open 1 AI co-innovation hub in London to shorten the path from drug target to first human dose. The partnership account says Novo will use Amazon Bio Discovery and Bedrock to connect genomic, imaging, and clinical data; our original OpenAI analysis argued that Novo needed a multi-vendor stack and measurable candidates, not one general-purpose provider. The call holds: AWS adds domain infrastructure and embedded engineers, but the verdict will not move until the hub advances a named candidate into Novo’s pipeline.